Effects of reduced gluten intake through the inclusion of yellow pea-based products on abdominal symptoms in habitual wheat consumers: a non-randomized clinical trial.
Shimbo H, Ito M, et al. • European journal of nutrition • 2026
Replacing wheat-based foods with yellow pea-based products (pasta, bread, and chips) over 4 weeks led to significant improvement in abdominal symptoms including distension, pain, incomplete evacuation, hard stools, and urgent defecation in habitual wheat consumers.
Key Findings
Results
A 4-week gluten-reduced diet intervention using yellow pea-based products significantly improved multiple abdominal symptoms in habitual wheat consumers.
Symptoms that improved significantly included abdominal distension, abdominal pain or discomfort, feeling of incomplete evacuation, hard stools, and urgent need for defecation.
Thirty men and women aged 18-64 years with habitual high wheat intake were enrolled.
Participants were divided into two groups based on the presence or absence of abdominal symptoms at baseline.
The intervention involved replacing wheat-based foods with yellow pea pasta (YPP), yellow pea bread (YPB), and yellow pea chips (YPC).
Results
Baseline quality of life differences between symptomatic and asymptomatic groups were no longer evident after the 4-week yellow pea-based dietary intervention.
QOL was evaluated before and after the intervention.
The symptomatic group had lower QOL at baseline compared to the asymptomatic group.
After the intervention, the QOL gap between the two groups was eliminated.
This suggests the intervention may have brought symptomatic participants' QOL closer to that of asymptomatic participants.
Results
Gut microbiota analysis revealed maintenance and/or increases in short-chain fatty acid (SCFA)-producing bacteria following the yellow pea-based diet intervention.
Gut microbiota composition was evaluated before and after the 4-week intervention.
Specific bacterial shifts were significantly correlated with symptom improvement.
SCFA-producing bacteria were maintained or increased, suggesting a potentially beneficial shift in microbiome composition.
The study design linked microbiota changes to clinical symptom outcomes through correlation analysis.
Background
The study enrolled habitual wheat consumers without requiring a diagnosis of celiac disease or wheat allergy, targeting individuals who may have non-celiac gluten sensitivity (NCGS).
Non-celiac gluten sensitivity (NCGS) was identified as a clinical entity distinct from wheat allergy and celiac disease.
Participants were healthy individuals with habitually high wheat intake, aged 18-64 years.
Thirty participants total were enrolled and divided into symptomatic and asymptomatic groups.
The study was registered in the UMIN Clinical Trials Registry (UMIN Trial ID: UMIN000056466) and was a non-randomized clinical trial.
Methods
Yellow pea-based products were evaluated as a gluten-reduced dietary strategy using three food formats: pasta, bread, and chips.
The three products tested were yellow pea pasta (YPP), yellow pea bread (YPB), and yellow pea chips (YPC).
The intervention duration was 4 weeks.
Outcome measures included abdominal symptoms, quality of life, gut microbiota, and selected blood biomarkers.
The study was a non-randomized clinical trial design.
What This Means
This research suggests that switching from regular wheat-based foods to yellow pea-based alternatives—specifically pasta, bread, and chips made from yellow peas—can meaningfully reduce uncomfortable digestive symptoms in people who regularly eat a lot of wheat. The 4-week study enrolled 30 adults and divided them into those who already experienced gut symptoms and those who did not. After the dietary change, participants who had been suffering from symptoms like bloating, abdominal pain, incomplete bowel emptying, hard stools, and sudden urges to use the bathroom showed significant improvements in all of these areas.
Beyond symptom relief, the study also found that quality of life improved in the symptomatic group to the point where their scores were comparable to the group that had no symptoms at baseline. Additionally, analysis of gut bacteria showed that the yellow pea diet was associated with maintaining or increasing bacteria that produce short-chain fatty acids—compounds generally considered beneficial for gut health—and these bacterial changes correlated with the symptom improvements observed.
This research matters because many people experience digestive discomfort after eating wheat but do not have celiac disease or a diagnosed wheat allergy, a condition sometimes called non-celiac gluten sensitivity. Despite their symptoms, these individuals often continue eating wheat because gluten-free options can be unappealing or impractical. Yellow pea-based products may offer a more accessible and palatable middle ground—reducing gluten intake without complete elimination—and could represent a practical dietary approach for managing wheat-related gut discomfort.
Shimbo H, Ito M, Aoki Y, Yoshimoto J, Kishi M, Saito J, et al.. (2026). Effects of reduced gluten intake through the inclusion of yellow pea-based products on abdominal symptoms in habitual wheat consumers: a non-randomized clinical trial.. European journal of nutrition. https://doi.org/10.1007/s00394-026-04097-2